Skip to content

Biodesix, Inc. BDSX Enterprise value

Enterprise value at other companies

NeoGenomics logo
NeoGenomicsNEO
$883.35M-5.6%
Veracyte logo
VeracyteVCYT
$2.33B+7.4%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$2.27B+78.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
$631.91M+125%
Guardant Health logo
Guardant HealthGH
$12.72B+121%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$7.64B-6.9%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Calculated from Biodesix, Inc.’s reported figures.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s enterprise value?
Biodesix, Inc. (BDSX) reported enterprise value of $188.98M in Q1 2026.
How has Biodesix, Inc.'s enterprise value changed year-over-year?
Biodesix, Inc.'s enterprise value increased by 39.0% year-over-year, from $135.93M to $188.98M.
What is the long-term trend for Biodesix, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Biodesix, Inc.'s enterprise value has grown at a -26.1% compound annual growth rate (CAGR), from $490.14M to $107.96M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.